Arcosa (ACA) Upgraded to Strong Buy: Here's Why
Arcosa (ACA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Arcosa (ACA) is an Incredible Growth Stock: 3 Reasons Why
Arcosa (ACA) could produce exceptional returns because of its solid growth attributes.
Wall Street Analysts Believe Arcosa (ACA) Could Rally 25.52%: Here's is How to Trade
The average of price targets set by Wall Street analysts indicates a potential upside of 25.5% in Arcosa (ACA). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Top Wind Energy Stocks to Keep an Eye on For Solid Returns
NEE, OGE, POR and ACA are capitalizing on soaring wind energy demand, with strong backlogs and expansion plans boosting growth.
3 Reasons Growth Investors Will Love Arcosa (ACA)
Arcosa (ACA) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Does Arcosa (ACA) Have the Potential to Rally 26.49% as Wall Street Analysts Expect?
The mean of analysts' price targets for Arcosa (ACA) points to a 26.5% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Arcosa, Inc. (ACA) Q1 2025 Earnings Call Transcript
Arcosa, Inc. (NYSE:ACA ) Q1 2025 Earnings Conference Call May 7, 2025 8:30 AM ET Company Participants Erin Drabek - Director of Investor Relations Antonio Carrillo - President and Chief Executive Officer Gail Peck - Chief Financial Officer Conference Call Participants Julio Romero - Sidoti & Company. Brent Thielman - D.A.
Arcosa (ACA) Q1 Earnings and Revenues Beat Estimates
Arcosa (ACA) came out with quarterly earnings of $0.49 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.73 per share a year ago.
New Strong Sell Stocks for May 2nd
ARCB, ACA and BAND have been added to the Zacks Rank #5 (Strong Sell) List on May 2, 2025.
CVS Beats Wall Street Expectations, Plans to Withdraw From ACA Business
The healthcare company also struck a deal with Novo Nordisk to sell Wegovy at a reduced price for cash-paying customers through its pharmacies.
Is the Options Market Predicting a Spike in Arcosa (ACA) Stock?
Investors need to pay close attention to Arcosa (ACA) stock based on the movements in the options market lately.
New Strong Sell Stocks for April 7th
ASTS, AMPY and ACA have been added to the Zacks Rank #5 (Strong Sell) List on April 7, 2025.
